Company Filing History:
6 out of 1,935 
2 out of 1,068 
Years Active: 2009-2019
Title: Innovations by Inventor Javier Cuevas
Introduction
Javier Cuevas is an accomplished inventor based in Lutz, Florida. He has made significant contributions to the field of therapeutics, particularly in the development of nanoparticle drug compositions. With a total of 6 patents to his name, Cuevas is recognized for his innovative approaches to treating various diseases of the central nervous system.
Latest Patents
One of Cuevas's latest patents is focused on the formulation of afobazole nanoparticles for enhanced therapeutics. This novel nanoparticle drug composition includes at least one nanoparticle carrier, created from the conjugation of PLGA and PEG, which encapsulates afobazole and its derivatives. This composition is designed to treat diseases involving excessive neuronal activity and inflammation, such as stroke, Alzheimer's disease, and anxiety.
Another significant patent involves the treatment of stroke using N,N'-di-1 naphthylguanidine HCl (NAGH) and N,N'-di-p-nitrophenylguanidine HCl (NAD) at delayed time points. This method presents a novel approach to treating stroke by administering sigma agonists. The research indicates that NAGH-treated rats showed improved vertical movement and reduced motor asymmetry compared to vehicle-treated rats. Both NAGH and NAD have demonstrated potential in extending the therapeutic window for stroke treatment.
Career Highlights
Javier Cuevas has worked with notable institutions such as the University of South Florida and the Charles Stark Draper Laboratory, Inc. His work has focused on advancing therapeutic methods and improving patient outcomes through innovative drug formulations.
Collaborations
Throughout his career, Cuevas has collaborated with esteemed colleagues, including Anilkumar Harapanahalli Achyuta and Shivshankar Sundaram. These collaborations have contributed to the success of his research and patent developments.
Conclusion
Javier Cuevas is a prominent inventor whose work in nanoparticle drug formulations and stroke treatment showcases his commitment to advancing medical science. His innovative patents and collaborations highlight his significant contributions to the field of therapeutics.